Sleep Disorders Trial, Recruiting NCT07340268 Sponsor: Zan Wang Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT07340268
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been clinically diagnosed with insomnia disorder
  • People who are willing and able to complete questionnaire surveys as part of the study

Who may not be able to join:

  • People who have a diagnosed mental health disorder
  • People who are currently using stimulant medications that affect the brain or nervous system
  • People who are currently using pain relievers, sedatives, sleeping medications, theophylline-based medications, or steroid medications
  • People who drink alcohol heavily or consume alcohol on a regular basis
  • People who have been diagnosed with another sleep disorder, such as sleep apnea, a condition involving abnormal movements or behaviours during sleep, or restless legs syndrome
  • People whose sleep problems are caused by another medical condition such as epilepsy, diabetes, or kidney failure
  • People who do shift work or have irregular working hours that interfere with their normal sleep-wake cycle
  • People who have used any medications that affect brain or nervous system function within the past month
  • People who have engaged in sleep-disrupting behaviours in the past two weeks, such as staying up late, drinking alcohol, or smoking
  • People who have abnormalities found on a brain MRI scan, or for whom an MRI scan would not be safe to perform

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 88782678

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Zan Wang
Registry
ClinicalTrials.gov
Start date
18 January 2026
Est. completion
30 November 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change in global blood-oxygen-level-dependent (gBOLD) signal amplitude; Change in resting-state functional connectivity strength; Change in amplitude of low-frequency fluctuations; Change in regional homogeneity; Change in phase difference of dynamic cerebral autoregulation; Change in gain of dynamic cerebral autoregulation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov